M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Revenue
zł750.8k
CAGR 3-Years
-41%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Revenue
zł462k
CAGR 3-Years
-68%
CAGR 5-Years
-28%
CAGR 10-Years
-19%
R
Ryvu Therapeutics SA
WSE:RVU
Revenue
zł63.6m
CAGR 3-Years
260%
CAGR 5-Years
22%
CAGR 10-Years
10%
S
Selvita SA
WSE:SLV
Revenue
zł329m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Revenue?
Revenue
750.8k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Revenue amounts to 750.8k PLN.

What is Medicofarma Biotech SA's Revenue growth rate?
Revenue CAGR 5Y
-31%

Over the last year, the Revenue growth was -82%. The average annual Revenue growth rates for Medicofarma Biotech SA have been -41% over the past three years , -31% over the past five years .

Back to Top